Statement Of Cash Flows [Abstract]

Zealand Pharma - Filing #1382857

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Interest paid, classified as operating activities
34,414,000 EUR
3,296,000 EUR
4,562,000 EUR
Interest received, classified as operating activities
5,178,000 EUR
0 EUR
895,000 EUR
Income taxes paid (refund), classified as operating activities
9,277,000 EUR
41,631,000 EUR
0 EUR
Cash flows from (used in) operating activities
942,209,000 EUR
1,211,971,000 EUR
688,716,000 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows from losing control of subsidiaries or other businesses, classified as investing activities
106,386,000 EUR
0 EUR
0 EUR
Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities
0 EUR
0 EUR
167,791,000 EUR
Purchase of property, plant and equipment, classified as investing activities
11,710,000 EUR
22,133,000 EUR
25,044,000 EUR
Cash flows from (used in) investing activities
281,259,000 EUR
18,121,000 EUR
196,807,000 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
1,060,825,000 EUR
748,975,000 EUR
791,503,000 EUR
Payments to acquire or redeem entity's shares
0 EUR
28,590,000 EUR
0 EUR
Proceeds from borrowings, classified as financing activities
0 EUR
647,906,000 EUR
0 EUR
Repayments of borrowings, classified as financing activities
436,088,000 EUR
0 EUR
0 EUR
Payments of lease liabilities, classified as financing activities
13,719,000 EUR
14,715,000 EUR
29,219,000 EUR
Cash flows from (used in) financing activities
587,398,000 EUR
1,332,751,000 EUR
760,941,000 EUR
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
73,552,000 EUR
102,659,000 EUR
124,582,000 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
13,683,000 EUR
66,223,000 EUR
3,743,000 EUR
Cash and cash equivalents
1,069,234,000 EUR
1,129,103,000 EUR
960,221,000 EUR
1,081,060,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.